Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 22, 2026 09:15 ET | Source: Pluri Inc.

Pluri Successfully Completes First Phase of Resbiomed Program for Placenta-Derived Collagen-Rich Biomaterials

HAIFA, Israel, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Pluri, Inc. (“Pluri”, the “Company”, “we” or “us”) (Nasdaq, TASE: PLUR), a biotechnology company leveraging its proprietary platform for cell-based...
January 22, 2026 09:00 ET | Source: MarketsandMarkets Research Pvt. Ltd.

Global Orthopedic Biomaterials Market on Track to Surpass USD 24.86 Billion by 2030 | MarketsandMarkets™

Delray Beach, FL, Jan. 22, 2026 (GLOBE NEWSWIRE) -- The Global orthopedic biomaterials market is projected to reach USD 24.86 billion by 2030 from USD 16.95 billion in 2025, at a CAGR of 8.0% from...
January 22, 2026 08:00 ET | Source: MBX Biosciences, Inc.

MBX Biosciences Appoints Laurie Stelzer to Board of Directors as Audit Committee Chair

CARMEL, Ind., Jan. 22, 2026 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel...
January 22, 2026 08:00 ET | Source: Corxel Pharmaceuticals

CORXEL Announces $287 million Series D1 Financing to Further Advance Its Cardiometabolic Pipeline including Oral Small Molecule GLP-1 Receptor Agonist

Series D1 financing with participation from a syndicate of global healthcare-focused investors, including RTW Investments, SR One Capital Management (SR One), TCG Crossover (TCGX), RA Capital...
January 22, 2026 07:30 ET | Source: Medicus Pharma Ltd

Medicus Pharma Ltd. Announces Amendment to LifeArc License Improving Teverelix® Long-Term Economic and Development Profile

Amendment reduces and simplifies royalty structure on Teverelix® from ~4% to 2% while preserving global rights and IP control The Company is developing Teverelix® as a first in class market product...
January 22, 2026 07:30 ET | Source: Diabetes Canada

Diabetes Canada awards nearly $6 million in funding to new research projects

Toronto, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Diabetes Canada is proud to announce the winners of its End Diabetes Awards, an annual competition that aims to improve the lives of people living with, or...
January 22, 2026 06:51 ET | Source: BCC Research LLC

BCC Research Releases Global Report on AI Disruption Across Industries and Regions

AI Disruption: A Global Overview,” artificial Intelligence is redefining the very foundations of industry and society.
January 22, 2026 06:30 ET | Source: Brown & Brown, Inc.

Brown & Brown launches fully integrated National Healthcare Practice

Brown & Brown launches a unified National Healthcare Practice, combining 140+ specialists to deliver integrated risk and insurance solutions for healthcare
January 22, 2026 06:00 ET | Source: Tilray Brands, Inc.

Tilray Medical Strengthens Italian Market Presence with the Launch of Tilray Medical Italia and Expanded Medical Cannabis Portfolio

NEW YORK and SAVONA, Italy, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Tilray Medical, a division of Tilray Brands, Inc. ("Tilray") (Nasdaq: TLRY; TSX: TLRY) and a global leader in medical cannabis,...
January 22, 2026 03:00 ET | Source: PulseSight Therapeutics S.A.S

Dosing completed in the Phase I clinical trial of PulseSight Therapeutics’ PST-611 treatment for dry AMD/Geographic Atrophy (GA)

PARIS, Jan. 22, 2026 (GLOBE NEWSWIRE) -- PulseSight Therapeutics SAS, an ophthalmology clinical stage biotech company developing disruptive vectorized gene therapies with minimally-invasive delivery...